Login / Signup

Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells.

William H PalmerLaura-Ann LeatonAna Campos CodoBergren W CruteJames RoestShiying ZhuJan PetersenRichard P TobinPatrick S HumeMatthew StoneAdrie van BokhovenMark E GerichMartin D McCarterYuwen ZhuWilliam J JanssenJulian P VivianJohn TrowsdaleAndrew GetahunJamie RossjohnJohn C CambierLiyen LohPaul J Norman
Published in: Science immunology (2023)
Most human killer cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) cells and recognize HLA class I molecules as ligands. KIR3DL3 is a conserved but polymorphic inhibitory KIR recognizing a B7 family ligand, HHLA2, and is implicated for immune checkpoint targeting. The expression profile and biological function of KIR3DL3 have been somewhat elusive, so we searched extensively for KIR3DL3 transcripts, revealing highly enriched expression in γδ and CD8 + T cells rather than NK cells. These KIR3DL3-expressing cells are rare in the blood and thymus but more common in the lungs and digestive tract. High-resolution flow cytometry and single-cell transcriptomics showed that peripheral blood KIR3DL3 + T cells have an activated transitional memory phenotype and are hypofunctional. The T cell receptor (TCR) usage is biased toward genes from early rearranged TCR-α variable segments or Vδ1 chains. In addition, we show that TCR-mediated stimulation can be inhibited through KIR3DL3 ligation. Whereas we detected no impact of KIR3DL3 polymorphism on ligand binding, variants in the proximal promoter and at residue 86 can reduce expression. Together, we demonstrate that KIR3DL3 is up-regulated alongside unconventional T cell stimulation and that individuals may vary in their ability to express KIR3DL3. These results have implications for the personalized targeting of KIR3DL3/HHLA2 checkpoint inhibition.
Keyphrases